Cite

HARVARD Citation

    Tarkin, J. et al. (n.d.). Use of somatostatin receptor PET to differentiate between high-risk and low-risk atherosclerotic lesions: a prospective clinical study. Lancet. pp. S97-. [Online]. 
  
Back to record